Examination of the mechanisms underlying the action of BPQDs@HSA as an immunosensitizer revealed that BPQDs@HSA enhances immune effects, relieves tumor‐derived immunosuppression of NK cells and inhibits the immune escape of tumor cells, leading to amplified anticancer efficacy. The gene discussed is ALB; the disease is neoplasm.